AG vs AGI

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating marginal stability, and lacks an Altman Z-Score, raising concerns about financial distress risk. Despite strong recent price performance and robust revenue growth (95.10% YoY), the stock appears significantly overvalued with a P/E of 169.60 versus sector average of 26.34 and a Graham Number of just $4.23, far below the current price of $25.44. Earnings quality is poor, with a track record of missing estimates in 3 of the last 4 quarters and an average surprise of -24.17%. While balance sheet metrics like low debt/equity (0.08) and strong liquidity (current ratio 3.38) are positives, weak ROE (4.21%) and inconsistent profitability undermine long-term value creation.

The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics and robust earnings growth, elevated valuation multiples and inconsistent quarterly earnings surprises weigh on sustainability. The stock trades significantly above the Graham Number of $16.89 and near the intrinsic value of $38.94, suggesting limited margin of safety. Analysts maintain a strong_buy consensus, but technical trend and insider sentiment are weak, indicating caution despite favorable sector-relative fundamentals.